...
【24h】

Salvage laparotomy for failure of peritoneal drainage in necrotizing enterocolitis in infants with extremely low birth weight.

机译:挽救剖腹术可降低出生体重极低的婴儿坏死性小肠结肠炎的腹膜引流失败。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND/PURPOSE: Peritoneal drainage is a temporizing procedure for infants with extremely low birth weight (ELBW) who have perforated necrotizing enterocolitis (NEC). "Salvage" laparotomy is advocated when patients worsen after drainage. Some patients have survived with intact gastrointestinal functional after drainage alone. The purpose of this study is to determine if these salvage laparotomies are beneficial. METHODS: The authors reviewed the records of ELBW infants treated at Stanford University with perforated NEC from 1993 through 1998. Data collected included demographic makeup, type of operation, survival rate, postoperative complications, length of stay (LOS), and cost. RESULTS: The authors treated 26 patients, 9 with laparotomy and 17 with peritoneal drainage. The peritoneal drainage group had lower birth weight and more comorbid conditions. Survival rate was similar between laparotomy and drainage: 55.6% versus 41.2%. Four patients in the drainage group underwent salvage laparotomy for perceived clinical deterioration. All of these patients died. The clinical status of patients who had salvage laparotomy and died was similar to those who did not and lived. Seven of 13 patients treated with drainage followed only by supportive care and antibiotics survived. Cost and LOS for patients undergoing salvage laparotomy were much greater than for nonsurviving patients undergoing only peritoneal drainage: 84 +/- 20 days and
机译:背景/目的:腹膜引流术是针对出生时极低体重(ELBW)的小儿穿孔坏死性小肠结肠炎(NEC)的临时性手术。当患者引流后恶化时,提倡“抢救”剖腹手术。一些患者仅通过引流就可以保留完整的胃肠道功能。这项研究的目的是确定这些挽救性剖腹手术是否有益。方法:作者回顾了1993年至1998年在斯坦福大学接受穿孔NEC治疗的ELBW婴儿的记录。收集的数据包括人口统计学,手术类型,生存率,术后并发症,住院时间(LOS)和费用。结果:作者治疗26例,开腹手术9例,腹膜引流17例。腹膜引流组出生体重较轻,合并症较多。开腹和引流的生存率相似:55.6%对41.2%。引流组中的四名患者因发现临床恶化而接受了剖腹手术。所有这些患者均死亡。进行挽救性剖腹手术而死亡的患者的临床状况与未幸存并存活的患者相似。接受引流治疗的13例患者中有7例仅接受支持治疗,而抗生素存活。进行挽救性剖腹手术的患者的成本和LOS比仅进行腹膜引流的未存活患者的成本和LOS高得多:84 +/- 20天,

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号